Esra Laloğlu

596 total citations
67 papers, 400 citations indexed

About

Esra Laloğlu is a scholar working on Surgery, Immunology and Infectious Diseases. According to data from OpenAlex, Esra Laloğlu has authored 67 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 13 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Esra Laloğlu's work include Inflammation biomarkers and pathways (8 papers), Pancreatitis Pathology and Treatment (6 papers) and COVID-19 Clinical Research Studies (5 papers). Esra Laloğlu is often cited by papers focused on Inflammation biomarkers and pathways (8 papers), Pancreatitis Pathology and Treatment (6 papers) and COVID-19 Clinical Research Studies (5 papers). Esra Laloğlu collaborates with scholars based in Türkiye, Cambodia and United States. Esra Laloğlu's co-authors include Handan Alay, Hülya Aksoy, Fatih Akçay, Kübra Koç, Fatime Geyikoğlu, Aysun Toker, Sabri Selçuk Atamanalp, Hamit Acemoğlu, Yasemin Çayır and Yılmaz Aksoy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Urology.

In The Last Decade

Esra Laloğlu

56 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Laloğlu Türkiye 13 69 62 57 56 38 67 400
Mustafa Keleş Türkiye 12 53 0.8× 41 0.7× 33 0.6× 56 1.0× 51 1.3× 40 418
Şenol Coşkun Türkiye 11 90 1.3× 84 1.4× 29 0.5× 31 0.6× 94 2.5× 56 451
Rodica Pădureanu Romania 11 81 1.2× 24 0.4× 47 0.8× 73 1.3× 108 2.8× 36 455
Ranna A. Rozenfeld United States 14 101 1.5× 98 1.6× 62 1.1× 74 1.3× 47 1.2× 30 486
Milić Veljović Serbia 9 61 0.9× 32 0.5× 65 1.1× 70 1.3× 157 4.1× 22 419
Kauser Usman India 12 72 1.0× 45 0.7× 18 0.3× 75 1.3× 64 1.7× 71 474
Qiao Zhang China 12 86 1.2× 45 0.7× 35 0.6× 96 1.7× 149 3.9× 59 593
Gila Gabay Israel 9 154 2.2× 88 1.4× 51 0.9× 117 2.1× 69 1.8× 14 471
Lü Ji China 11 60 0.9× 36 0.6× 35 0.6× 98 1.8× 45 1.2× 18 534
M. G. Sridhar India 16 77 1.1× 55 0.9× 28 0.5× 73 1.3× 111 2.9× 36 656

Countries citing papers authored by Esra Laloğlu

Since Specialization
Citations

This map shows the geographic impact of Esra Laloğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Laloğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Laloğlu more than expected).

Fields of papers citing papers by Esra Laloğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Laloğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Laloğlu. The network helps show where Esra Laloğlu may publish in the future.

Co-authorship network of co-authors of Esra Laloğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Laloğlu. A scholar is included among the top collaborators of Esra Laloğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Laloğlu. Esra Laloğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laloğlu, Esra, et al.. (2025). Can apelins guide the diagnosis of coronary artery disease in COPD patients?. Heart & Lung. 71. 90–97. 1 indexed citations
2.
Laloğlu, Esra, et al.. (2024). Salivary and serum asprosin hormone levels in the 2018 EFP/AAP classification of periodontitis stages and body mass index status: a case-control study. Clinical Oral Investigations. 28(1). 91–91. 2 indexed citations
3.
4.
Laloğlu, Esra, et al.. (2024). CXCL12/CXCR4 as a potential axis in diagnosis and predicting disease severity in COVID-19 patients: a new perspective. SHILAP Revista de lepidopterología. 49(4). 578–585.
5.
Yanık, Ahmet, Handan Alay, & Esra Laloğlu. (2024). Bruselloz Hastalarında Serum sTREM-1, Presepsin ve IFN-Gama Düzeylerinin Tanıdaki Yeri. Mikrobiyoloji Bulteni. 58(4). 422–432.
6.
Aydın, Hasan Riza, et al.. (2024). Diagnostic Value of Serum and Urine Endocan Levels in Nonmuscle Invasive Bladder Cancer: A Prospective Comparative Study. International Journal of Clinical Practice. 2024. 1–7. 1 indexed citations
7.
8.
Laloğlu, Esra, et al.. (2023). The CXCL9/10/11-CXCR3 axis as a predictor of COVID-19 progression: a prospective, case-control study. Revista da Sociedade Brasileira de Medicina Tropical. 56. e01282023–e01282023. 6 indexed citations
9.
Laloğlu, Esra, et al.. (2023). Serum Occludin and Zonulin Levels in Children With Attention-Deficit/Hyperactivity Disorder and Healthy Controls. Indian Pediatrics. 60(2). 137–141. 8 indexed citations
10.
11.
12.
13.
Alay, Handan & Esra Laloğlu. (2022). Can Endocan Be a Novel Marker in the Diagnosis of Brucellosis?. Vector-Borne and Zoonotic Diseases. 22(4). 232–237. 1 indexed citations
14.
Laloğlu, Esra & Handan Alay. (2022). Role of transforming growth factor-beta 1 and connective tissue growth factor levels in coronavirus disease-2019-related lung Injury: a prospective, observational, cohort study. Revista da Sociedade Brasileira de Medicina Tropical. 55. e06152021–e06152021. 15 indexed citations
15.
Parlak, Emine & Esra Laloğlu. (2022). Analysis of Chitinase-3-Like Protein 1, IL-1-Alpha, and IL-6 as Novel Inflammatory Biomarkers for COVID-19. Journal of Interferon & Cytokine Research. 42(10). 536–541. 8 indexed citations
16.
Alay, Handan, et al.. (2021). An evaluation of ischaemia‐modified albumin levels in the development of diabetic foot ulcer. International Journal of Clinical Practice. 75(9). e14589–e14589. 10 indexed citations
17.
Alay, Handan & Esra Laloğlu. (2021). The role of angiopoietin‐2 and surfactant protein‐D levels in SARS‐CoV‐2‐related lung injury: A prospective, observational, cohort study. Journal of Medical Virology. 93(10). 6008–6015. 24 indexed citations
18.
Parlak, Emine, Ferhan Kerget, Tuna Demırdal, et al.. (2021). The Epidemiology, Clinical Manifestations, Radiology, Microbiology, Treatment, and Prognosis of Echinococcosis: Results of NENEHATUN Study. Vector-Borne and Zoonotic Diseases. 21(12). 948–954. 2 indexed citations
19.
Laloğlu, Esra, et al.. (2019). Hepatoprotective potential of Ferula communis extract for carbon tetrachloride induced hepatotoxicity and oxidative damage in rats. Biotechnic & Histochemistry. 94(5). 334–340. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Keleş Breakdown of academic impact, for papers by Şenol Coşkun Breakdown of academic impact, for papers by Rodica Pădureanu Breakdown of academic impact, for papers by Ranna A. Rozenfeld Breakdown of academic impact, for papers by Milić Veljović Breakdown of academic impact, for papers by Kauser Usman Breakdown of academic impact, for papers by Qiao Zhang Breakdown of academic impact, for papers by Gila Gabay Breakdown of academic impact, for papers by Lü Ji Breakdown of academic impact, for papers by M. G. Sridhar
Rankless by CCL
2026